Adalimumab with or without methotrexate in juvenile rheumatoid arthritis

The New England Journal of Medicine
Daniel J LovellPediatric Rheumatology International Trials Organisation

Abstract

Tumor necrosis factor (TNF) has a pathogenic role in juvenile rheumatoid arthritis. We evaluated the efficacy and safety of adalimumab, a fully human monoclonal anti-TNF antibody, in children with polyarticular-course juvenile rheumatoid arthritis. Patients 4 to 17 years of age with active juvenile rheumatoid arthritis who had previously received treatment with nonsteroidal antiinflammatory drugs underwent stratification according to methotrexate use and received 24 mg of adalimumab per square meter of body-surface area (maximum dose, 40 mg) subcutaneously every other week for 16 weeks. We randomly assigned patients with an American College of Rheumatology Pediatric 30% (ACR Pedi 30) response at week 16 to receive adalimumab or placebo in a double-blind fashion every other week for up to 32 weeks. Seventy-four percent of patients not receiving methotrexate (64 of 86) and 94% of those receiving methotrexate (80 of 85) had an ACR Pedi 30 response at week 16 and were eligible for double-blind treatment. Among patients not receiving methotrexate, disease flares (the primary outcome) occurred in 43% of those receiving adalimumab and 71% of those receiving placebo (P=0.03). Among patients receiving methotrexate, flares occurred in 37...Continue Reading

References

Jul 1, 1997·Arthritis and Rheumatism·E H GianniniA Martini
Apr 20, 2001·JAMA : the Journal of the American Medical Association·D MoherUNKNOWN CONSORT Group (Consolidated Standards of Reporting Trials)
Apr 13, 2004·Arthritis and Rheumatism·R N MainiUNKNOWN Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group
Mar 6, 2007·Lancet·Angelo Ravelli, Alberto Martini

❮ Previous
Next ❯

Citations

Feb 9, 2011·European Journal of Clinical Pharmacology·Paola BaiardiUNKNOWN TEDDY Network of Excellence
Nov 16, 2011·Rheumatology International·A HeiligenhausUNKNOWN German Society for Rheumatology
Jul 16, 2010·Zeitschrift für Rheumatologie·D HolzingerD Föll
Jul 30, 2010·Zeitschrift für Rheumatologie·G Dückers, T Niehues
Aug 28, 2010·Zeitschrift für Rheumatologie·G Horneff
Mar 27, 2009·Clinical Rheumatology·María M Katsicas, Ricardo A G Russo
Jan 20, 2012·Modern Rheumatology·Shumpei YokotaMasaaki Mori
Apr 23, 2013·Current Allergy and Asthma Reports·Julia G HarrisJames W Verbsky
Mar 27, 2013·Current Rheumatology Reports·Andrew Hurd, Timothy Beukelman
Oct 1, 2008·World Journal of Pediatrics : WJP·Nicolino Ruperto, Alberto Martini
Jun 2, 2009·Nature Reviews. Drug Discovery·Matthias GaestelMichael Kracht
Sep 3, 2010·Nature Reviews. Rheumatology·Philip J HashkesRonald M Laxer
Jul 11, 2013·Nature Reviews. Rheumatology·Daniel J LovellAlberto Martini
Dec 5, 2008·The New England Journal of Medicine·Paolo Sfriso, Francesca Ravaioli
Aug 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sima S ToussiThomas J Walsh
Feb 10, 2009·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Sofia LionakiJohn Boletis
Nov 5, 2010·Rheumatology·Taunton R SouthwoodUNKNOWN British Society for Adolescent and Paediatric Rheumatology Biologics and New Drugs Register
Dec 15, 2010·Rheumatology·Gerd HorneffToni Hospach
Jan 26, 2011·JAAPA : Official Journal of the American Academy of Physician Assistants·Melissa Isennock, John M Grosel
Apr 4, 2009·Current Opinion in Rheumatology·Alexandra Villa-Forte
Aug 24, 2010·Current Opinion in Ophthalmology·Ying Qian, Nisha R Acharya
Apr 21, 2011·Pediatric Dermatology·Antonio Chaves AlvarezAntonio Zambrano
Nov 23, 2012·Annals of the Rheumatic Diseases·Marieke H OttenLisette W A van Suijlekom-Smit
Mar 20, 2010·Annals of the Rheumatic Diseases·Nicolino RupertoUNKNOWN Pediatric Rheumatology Collaborative Study Group (PRCSG)
Aug 8, 2012·Therapeutic Advances in Musculoskeletal Disease·Natasha M Ruth, Murray H Passo
Jun 16, 2010·Pediatric Rheumatology Online Journal·Peter McCroskeryDebra J Zack
Feb 24, 2009·Arthritis Research & Therapy·Vibeke Strand, Jeremy Sokolove
Mar 18, 2009·Arthritis Research & Therapy·Kristen Hayward, Carol A Wallace

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.